GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RP Bio lnc (XKRX:314140) » Definitions » EV-to-EBITDA

RP Bio lnc (XKRX:314140) EV-to-EBITDA : 7.08 (As of May. 14, 2024)


View and export this data going back to 2022. Start your Free Trial

What is RP Bio lnc EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, RP Bio lnc's enterprise value is ₩95,553 Mil. RP Bio lnc's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩13,502 Mil. Therefore, RP Bio lnc's EV-to-EBITDA for today is 7.08.

The historical rank and industry rank for RP Bio lnc's EV-to-EBITDA or its related term are showing as below:

XKRX:314140' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.62   Med: 9.35   Max: 12.61
Current: 7.08

During the past 4 years, the highest EV-to-EBITDA of RP Bio lnc was 12.61. The lowest was 4.62. And the median was 9.35.

XKRX:314140's EV-to-EBITDA is ranked better than
80.54% of 704 companies
in the Drug Manufacturers industry
Industry Median: 14.705 vs XKRX:314140: 7.08

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-14), RP Bio lnc's stock price is ₩8940.00. RP Bio lnc's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩780.000. Therefore, RP Bio lnc's PE Ratio for today is 11.46.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


RP Bio lnc EV-to-EBITDA Historical Data

The historical data trend for RP Bio lnc's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RP Bio lnc EV-to-EBITDA Chart

RP Bio lnc Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
- - - 10.00

RP Bio lnc Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.00 13.69 12.00 7.80 6.89

Competitive Comparison of RP Bio lnc's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, RP Bio lnc's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RP Bio lnc's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RP Bio lnc's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where RP Bio lnc's EV-to-EBITDA falls into.



RP Bio lnc EV-to-EBITDA Calculation

RP Bio lnc's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=95552.973/13501.561
=7.08

RP Bio lnc's current Enterprise Value is ₩95,553 Mil.
RP Bio lnc's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩13,502 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RP Bio lnc  (XKRX:314140) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

RP Bio lnc's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=8940.00/780.000
=11.46

RP Bio lnc's share price for today is ₩8940.00.
RP Bio lnc's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩780.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


RP Bio lnc EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of RP Bio lnc's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


RP Bio lnc (XKRX:314140) Business Description

Traded in Other Exchanges
N/A
Address
634, Samseong-ro, Gangnam-gu, Seoul, KOR, 06084
RP Bio lnc is engaged in the pharmaceutical manufacturing business. It produces softgels, finished drugs, and other products.

RP Bio lnc (XKRX:314140) Headlines

No Headlines